PureTech Health Net Worth
PureTech Health Net Worth Breakdown | PRTC |
PureTech Health Net Worth Analysis
PureTech Health's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including PureTech Health's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of PureTech Health's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform PureTech Health's net worth analysis. One common approach is to calculate PureTech Health's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares PureTech Health's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing PureTech Health's net worth. This approach calculates the present value of PureTech Health's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of PureTech Health's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate PureTech Health's net worth. This involves comparing PureTech Health's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into PureTech Health's net worth relative to its peers.
Enterprise Value |
|
To determine if PureTech Health is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding PureTech Health's net worth research are outlined below:
| PureTech Health PLC currently holds about 368.03 M in cash with (134.37 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 12.84. | |
| Latest headline from gurufocus.com: PureTech Founded Entity Seaport Therapeutics Announces First Pat |
PureTech Health uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in PureTech Health PLC. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to PureTech Health's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 26th of April 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 26th of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know PureTech Health's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as PureTech Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading PureTech Health PLC backward and forwards among themselves. PureTech Health's institutional investor refers to the entity that pools money to purchase PureTech Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Birch Hill Investment Advisors Llc | 2025-03-31 | 302 K | Millennium Management Llc | 2025-03-31 | 44.9 K | Pentwater Capital Management Lp | 2025-03-31 | 33.6 K | Portolan Capital Management, Llc | 2025-03-31 | 11.9 K | Morgan Stanley - Brokerage Accounts | 2025-03-31 | 100.0 | Ubs Group Ag | 2025-03-31 | 20.0 | Adar1 Capital Management Llc | 2024-12-31 | 0.0 |
Follow PureTech Health's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 472.51 M.Market Cap |
|
Project PureTech Health's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.09 | 0.09 | |
| Return On Capital Employed | (0.24) | (0.23) | |
| Return On Assets | 0.09 | 0.09 | |
| Return On Equity | 0.13 | 0.09 |
When accessing PureTech Health's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures PureTech Health's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of PureTech Health's profitability and make more informed investment decisions.
Please note, the presentation of PureTech Health's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, PureTech Health's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of PureTech Health's management manipulating its earnings.
Evaluate PureTech Health's management efficiency
PureTech Health PLC has return on total asset (ROA) of (0.131) % which means that it has lost $0.131 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0642 %, meaning that it created $0.0642 on every $100 dollars invested by stockholders. PureTech Health's management efficiency ratios could be used to measure how well PureTech Health manages its routine affairs as well as how well it operates its assets and liabilities. At present, PureTech Health's Return On Assets are projected to increase slightly based on the last few years of reporting. At present, PureTech Health's Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 10.6 M, whereas Total Assets are forecasted to decline to about 554 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 1.51 | 1.86 | |
| Tangible Book Value Per Share | 1.51 | 1.84 | |
| Enterprise Value Over EBITDA | 126.25 | 132.57 | |
| Price Book Value Ratio | 1.20 | 1.26 | |
| Enterprise Value Multiple | 6.41 | 6.73 | |
| Price Fair Value | 1.20 | 1.26 | |
| Enterprise Value | 4.7 B | 4.6 B |
Understanding the operational decisions made by PureTech Health management offers insights into its financial robustness. This evaluation is crucial for assessing the stock's investment potential.
Enterprise Value Revenue 22.6625 | Revenue | Quarterly Revenue Growth 24.222 | Revenue Per Share | Return On Equity |
PureTech Health Corporate Filings
6K | 16th of July 2025 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
| 12th of February 2025 Other Reports | ViewVerify | |
13A | 12th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
13A | 7th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
PureTech Health Earnings per Share Projection vs Actual
PureTech Health Corporate Management
| Frank Salisbury | Senior Strategy | Profile | |
| Anita JD | Senior Property | Profile | |
| Lauren MBA | Chief Officer | Profile | |
| David Elmaleh | CoFounder Advisor | Profile | |
| Spencer Ball | Executive Resources | Profile | |
| III JD | General Secretary | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PureTech Health PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PureTech Health. If investors know PureTech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PureTech Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.615 | Earnings Share 2.1 | Revenue Per Share | Quarterly Revenue Growth 24.222 | Return On Assets |
The market value of PureTech Health PLC is measured differently than its book value, which is the value of PureTech that is recorded on the company's balance sheet. Investors also form their own opinion of PureTech Health's value that differs from its market value or its book value, called intrinsic value, which is PureTech Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PureTech Health's market value can be influenced by many factors that don't directly affect PureTech Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PureTech Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if PureTech Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PureTech Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.